FIELD: medicine, pulmonology. SUBSTANCE: drug has starch, agarose, preserving agent, among them dioxydine and sulfalene-megluminate, and physiological solution and if necessary acceptable special additions. Agent does not irritate nasal mucosa and does not suppress the ciliated epithelium transport function, well removed and ensures to refuse the use of a lot of medicinal additions. Agent is used for treatment of inflammatory diseases of upper respiratory tract. EFFECT: enhanced effectiveness of drug. 4 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF PATIENT WITH SUPPURATIVE HIGHMORITIS | 1997 |
|
RU2134114C1 |
COMPOSITIONS AND METHODS OF TREATING PARANASAL SINUS AND PARASITIC NASAL MUCOSA DISEASES WITH NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS | 2017 |
|
RU2718061C1 |
METHOD OF PURULENT HIGHMORITIS TREATMENT | 0 |
|
SU1822771A1 |
AGENT FOR X-RAY CONTRAST INVESTIGATION OF CAVITIES | 0 |
|
SU1097273A1 |
METHOD OF TREATMENT OF CHRONIC PURULENT RHINOSINUSITIS | 2007 |
|
RU2345784C1 |
METHOD OF TREATMENT OF ADENORINOSINUSITIS | 2017 |
|
RU2662925C1 |
METHOD OF TREATMENT OF ACUTE SUPRAMAXILLARY SINUSITIS | 2007 |
|
RU2343920C1 |
METHOD FOR CONSERVATIVE TREATMENT OF CHRONIC ADENOIDITIS | 2002 |
|
RU2290932C2 |
METHOD OF EVALUATING THE EFFICIENCY OF MEDICAMENTAL THERAPY OF ACUTE EXACERBATIONS OF CHRONIC PURULENT SINUSITIS | 2015 |
|
RU2600645C2 |
METHOD AND APPARATUS FOR TREATMENT OF SINUITIS | 0 |
|
SU1311714A1 |
Authors
Dates
1998-07-20—Published
1997-07-09—Filed